These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27975253)

  • 1. Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In Vivo.
    Yuzwa SA; Vocadlo DJ
    Methods Mol Biol; 2017; 1523():237-248. PubMed ID: 27975253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
    Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
    J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400.
    Cameron A; Giacomozzi B; Joyce J; Gray A; Graham D; Ousson S; Neny M; Beher D; Carlson G; O'Moore J; Shearman M; Hering H
    FEBS Lett; 2013 Nov; 587(22):3722-8. PubMed ID: 24113653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice.
    Hastings NB; Wang X; Song L; Butts BD; Grotz D; Hargreaves R; Fred Hess J; Hong KK; Huang CR; Hyde L; Laverty M; Lee J; Levitan D; Lu SX; Maguire M; Mahadomrongkul V; McEachern EJ; Ouyang X; Rosahl TW; Selnick H; Stanton M; Terracina G; Vocadlo DJ; Wang G; Duffy JL; Parker EM; Zhang L
    Mol Neurodegener; 2017 May; 12(1):39. PubMed ID: 28521765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
    Yuzwa SA; Yadav AK; Skorobogatko Y; Clark T; Vosseller K; Vocadlo DJ
    Amino Acids; 2011 Mar; 40(3):857-68. PubMed ID: 20706749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc modification and the tauopathies: insights from chemical biology.
    Yuzwa SA; Vocadlo DJ
    Curr Alzheimer Res; 2009 Oct; 6(5):451-4. PubMed ID: 19874270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
    Ahmad W; Shabbiri K; Ahmad I
    Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-8719, a Novel and Selective
    Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
    J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
    Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
    Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
    Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
    Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.
    Yuzwa SA; Shan X; Macauley MS; Clark T; Skorobogatko Y; Vosseller K; Vocadlo DJ
    Nat Chem Biol; 2012 Feb; 8(4):393-9. PubMed ID: 22366723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
    Yuzwa SA; Vocadlo DJ
    Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.
    Ryan P; Xu M; Davey AK; Danon JJ; Mellick GD; Kassiou M; Rudrawar S
    ACS Chem Neurosci; 2019 May; 10(5):2209-2221. PubMed ID: 30985105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway.
    Zhu Y; Shan X; Safarpour F; Erro Go N; Li N; Shan A; Huang MC; Deen M; Holicek V; Ashmus R; Madden Z; Gorski S; Silverman MA; Vocadlo DJ
    ACS Chem Neurosci; 2018 Jun; 9(6):1366-1379. PubMed ID: 29460617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-synthesis of a tag-free O-GlcNAcylated tau protein by sequential chemoselective ligation.
    Schwagerus S; Reimann O; Despres C; Smet-Nocca C; Hackenberger CP
    J Pept Sci; 2016 May; 22(5):327-33. PubMed ID: 27071766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease.
    Yao PJ; Coleman PD
    J Neurosci; 1998 Apr; 18(7):2399-411. PubMed ID: 9502801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of xixin decoction on O-linked N-acetylglucosamine glycosylation of tau proteins in rat brain with sporadic Alzheimer disease.
    Diwu Y; Tian J; Shi J
    J Tradit Chin Med; 2013 Jun; 33(3):367-72. PubMed ID: 24024334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.